Matthew D. Petroski
Pfizer (United States)(US)Université Bourgogne Franche-Comté(FR)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Endoplasmic Reticulum Stress and Disease, Advanced Breast Cancer Therapies, Autophagy in Disease and Therapy
Most-Cited Works
- → Function and regulation of cullin–RING ubiquitin ligases(2005)2,116 cited
- → N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells(2014)1,318 cited
- → Mechanism of Lysine 48-Linked Ubiquitin-Chain Synthesis by the Cullin-RING Ubiquitin-Ligase Complex SCF-Cdc34(2005)305 cited
- → The ubiquitin system, disease, and drug discovery(2008)177 cited
- → Context of Multiubiquitin Chain Attachment Influences the Rate of Sic1 Degradation(2003)147 cited
- → REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase(2009)144 cited
- → CAND1 controls in vivo dynamics of the cullin 1-RING ubiquitin ligase repertoire(2013)